Ambulero is a cell and gene therapy spin-out of the University of Miami focused on advancing new therapies to fight vascular disease. A platform company that can deliver the adhesion molecule E-selectin using different cell and synthetic vector technologies.

Biotechnology

Ambulero

Ambulero's headquarters in Miami, FL, United States

Robert L. Buchanan

Randy Berholtz

Omaida Caridad Velazquez

Carlton Anderson

Khemraj Hirani

Zhao-Jun Liu

Gregory Landry

Ambulero's Leadership Team includes Zhao-Jun Liu and 4 others.

About

People

Carlton Anderson

Khemraj Hirani

Omaida Caridad Velazquez

Robert L. Buchanan

Zhao-Jun Liu